Latent autoimmune diabetes in adults in China [PDF]
Frontiers in Immunology, 2022 Latent autoimmune diabetes in adults (LADA) is a type of diabetes caused by slow progression of autoimmune damage to pancreatic beta cells. According to the etiological classification, LADA should belong to the autoimmune subtype of type 1 diabetes (T1D).
Junlin Qiu +4 more
doaj +4 more sources
Latent Autoimmune Diabetes in Adults: A Case Report [PDF]
Oman Medical JournalLatent autoimmune diabetes in adults (LADA) is a slow progressive autoimmune destruction of pancreatic beta cells. This condition tends to manifest during adulthood, often around 35 years of age.
Khalid Shaikh, Natasha Mathew
doaj +4 more sources
Editorial: Latent Autoimmune Diabetes in Adults (LADA) [PDF]
Frontiers in Endocrinology, 2022 Richard David Leslie
doaj +4 more sources
A Review on Latent Autoimmune Diabetes in Adults. [PDF]
Cureus, 2023 Latent autoimmune diabetes (LADA) is an unique form of diabetes that has characteristics of both type 1 and type 2 diabetes. Type 1.5 diabetes also known as LADA is occasionally confused for type 2 diabetes because there is delay in presenting features and early insulin independence.
Ravikumar V, Ahmed A, Anjankar A.
europepmc +3 more sources
Prevalence of latent autoimmune diabetes in adults and insulin resistance: a systematic review and meta-analysis [PDF]
European Journal of Translational MyologyLatent autoimmune diabetes in adults is a form of diabetes that progresses slowly and is controlled by diet and oral glucose-lowering medications before insulin is required. The aim of the present study was to evaluate the prevalence of latent autoimmune
Malihe Mohammadi
doaj +2 more sources
Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis [PDF]
Journal of Diabetes Investigation, 2022 Aims/Introduction The optimal therapy for latent autoimmune diabetes in adults (LADA) remains undefined. Increasing evidence has shown that sitagliptin and insulin treatment can benefit patients with LADA, but the efficacy still lacks systematic ...
Tong Lin +5 more
doaj +2 more sources
Latent Autoimmune Diabetes in Adults: Autoimmune Diabetes in Adults with Slowly Progressive β-cell Failure [PDF]
Diabetes & Metabolism Journal, 2012 Type 1 diabetes (T1D) is caused by interactions of genetic predisposition, immunologic triggers, and environmental events leading to autoimmune-mediated pancreatic β-cell destruction and insulin deficiency, although some subjects show lack of autoantibodies to pancreatic islets.
Hannah Seok, Byung Wan Lee
doaj +3 more sources
Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy [PDF]
Frontiers in Endocrinology, 2022 Latent autoimmune diabetes in adults (LADA) is a type of diabetes characterized by slow autoimmune damage of pancreatic β cells without insulin treatment in the early clinical stage.
Jingyi Hu +5 more
doaj +2 more sources
Innate immunity in latent autoimmune diabetes in adults. [PDF]
Diabetes Metab Res Rev, 2022 Abstract Latent autoimmune diabetes in adults (LADA) is an autoimmune disease that shares some genetic, immunological and clinical features with both type 1 diabetes and type 2 diabetes. Immune cells including CD4 + T cells, CD8 + T ...
Huang J +4 more
europepmc +4 more sources
Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review [PDF]
Frontiers in Endocrinology, 2022 Latent autoimmune diabetes in adults (LADA) is a heterogeneous subtype of diabetes characterized by islet cell destruction mediated by islet autoimmunity and insulin resistance.
Niansi Pan, Shimei Yang, Xiaohong Niu
doaj +2 more sources